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Abstract
Background: The study investigated the distribution of silver after 28 days repeated oral administration of silver
nanoparticles (AgNPs) and silver acetate (AgAc) to rats. Oral administration is a relevant route of exposure because
of the use of silver nanoparticles in products related to food and food contact materials.
Results: AgNPs were synthesized with a size distribution of 14 ± 4 nm in diameter (90% of the nanoparticle volume)
and stabilized in aqueous suspension by the polymer polyvinylpyrrolidone (PVP). The AgNPs remained stable
throughout the duration of the 28-day oral toxicity study in rats. The organ distribution pattern of silver following
administration of AgNPs and AgAc was similar. However the absolute silver concentrations in tissues were lower
following oral exposure to AgNPs. This was in agreement with an indication of a higher fecal excretion following
administration of AgNPs. Besides the intestinal system, the largest silver concentrations were detected in the liver and
kidneys. Silver was also found in the lungs and brain. Autometallographic (AMG) staining revealed a similar cellular
localization of silver in ileum, liver, and kidney tissue in rats exposed to AgNPs or AgAc.
Using transmission electron microscopy (TEM), nanosized granules were detected in the ileum of animals exposed
to AgNPs or AgAc and were mainly located in the basal lamina of the ileal epithelium and in lysosomes of
macrophages within the lamina propria. Using energy dispersive x-ray spectroscopy it was shown that the granules
in lysosomes consisted of silver, selenium, and sulfur for both AgNP and AgAc exposed rats. The diameter of the
deposited granules was in the same size range as that of the administered AgNPs. No silver granules were
detected by TEM in the liver.
Conclusions: The results of the present study demonstrate that the organ distribution of silver was similar when
AgNPs or AgAc were administered orally to rats. The presence of silver granules containing selenium and sulfur in
the intestinal wall of rats exposed to either of the silver forms suggests a common mechanism of their formation.
Additional studies however, are needed to gain further insight into the underlying mechanisms of the granule
formation, and to clarify whether AgNPs dissolve in the gastrointestinal system and/or become absorbed and
translocate as intact nanoparticles to organs and tissues.
Background
Silver nanoparticles (AgNPs) are presently one of the
most frequently used nanomaterials in consumer pro-
ducts [1] because of their proposed antimicrobial prop-
erties [2]. Silver in the form of Ag+ ions has toxic effects
on many pathogens, including bacteria, viruses, and
fungi [3]. Because of its relatively low toxicity in
humans, silver has been used in various medical applica-
tions [4]. The antibacterial activity of AgNPs also
depends on the Ag+ ion [3], which is readily formed on
the nanoparticle surface due to reaction with oxygen.
The antibacterial activity of AgNPs increases with
decreasing particle size which has been associated with
the increasing surface area-to-mass ratio [3].
In general, application of nanoparticles in products
related to food and beverages is still rare [5]. AgNPs
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however, can already be found in a number of commer-
cial products including food packing materials and
kitchen appliances, and is even sold as an alternative
“health supplement” [5,6]. Furthermore, silver nanoparti-
cles are considered as a potential additive to animal feed
to replace antibiotics [7,8]. Therefore, oral intake of sil-
ver nanoparticles is a relevant route of exposure for the
consumer.
The toxicology of silver and its compounds has been
studied for decades. Animal studies dealing with oral
exposure to silver are nevertheless scarce. A summary of
the available data has been given in the “Toxicological
Profile for Silver” from the Agency for Toxic Substances
and Disease Registry of the U.S. Public Health Service
[9]. Although the toxicology of silver and its compounds
has been studied, several knowledge gaps exist concern-
ing the risk caused by silver in the form of nanoparti-
cles, both to humans and to the environment [10]. It is
for example not known to what extent intact AgNPs
themselves enter the body or whether only silver ions
originating from the nanoparticles are absorbed.
It is generally known that nanoparticles can be taken
up by the intestinal system not only via M-cells in the
Peyer’s patches and the isolated follicles of the intest-
inal-associated lymphoid tissue, but also via enterocytes
[11]. The degree of absorption is mainly governed by
nanoparticle size, surface charge, hydrophobicity, and
the presence or absence of surface ligands. It is generally
agreed that absorption increases with decreasing particle
diameter for sizes below 1 μm [12]. Thus, aggregation of
nanoparticles in the lumen of the gastro-intestinal tract
can lead to decreased absorption.
In a 28-day repeated oral dose toxicity study, AgNPs of
60 nm in diameter and stabilized by 0.5% aqueous carbox-
ymethylcellulose, were administered to rats [13]. A dose-
dependent increase of the silver concentration in the rat
organs was observed with the highest concentrations in
stomach, kidney and liver. However, it was not investi-
gated whether the silver reached the tissues and organs as
nanoparticles. Animal studies using other exposure routes
revealed that intact AgNPs indeed could translocate to
and deposit in a variety of organs of experimental animals.
Following subcutaneous injection of 50-100 nm diameter
AgNPs, discrete nanoparticles were found in kidney, liver,
spleen, and lung tissue, as well as in vascular endothelial
cells of the blood-brain barrier [14]. Intraperitoneally
injected bovine serum albumin (BSA)-coated AgNPs of
2 nm in diameter were detected as larger aggregates in
liver, kidney, and heart tissue, which was attributed to coa-
lescence or aggregation events taking place in the blood
serum or in the tissue [15].
The aim of the present study was to investigate the
organ distribution and cellular localization of silver in
rats following 28 days repeated oral exposure of either
AgNPs or silver acetate (AgAc). AgNPs were sterically
stabilized with a polymer to assure the availability of
well-characterized and stable nanoparticles throughout
the duration of the animal experiment. AgAc was cho-
sen for comparison because it is a soluble salt contain-
ing a biocompatible counter ion. Transmission electron
microscopy (TEM) was applied to investigate whether
intact AgNPs entered the intestinal wall of rats.
Methods
Unless stated otherwise, results based on repeated mea-
surements are given as mean ± 1s.d. The number of
repetitions N is stated in parentheses.
Synthesis of the AgNPs
AgNPs were produced by reducing silver nitrate with
hydrazine in the presence of polyvinylpyrrolidone (PVP)
[16]. An amount of 300 mg of PVP powder (PVP-K30,
BASF Ludwigshafen, Germany) was dissolved in 8 ml of
an aqueous 25 mM silver nitrate solution (AgNO3, A.R
Beijing Chemical Factory, China). The mixture was
diluted with 14 ml deionized water. After 5 min at room
temperature 4 ml of 70 mM hydrazine (N2H4·H20, A.R
Beijing Zhonglian Reagent Fine Chemicals Co., Ltd.,
China) was added dropwise. Hydrazine was added in stoi-
chiometric excess to achieve complete reduction of the
silver salt. All steps were performed under continuous
stirring. The final suspension was purified by centrifuga-
tion at 4,000 rpm (1,467 × g) for 10 min and by dialysis
for 24 h against deionized water using a 14 kDa mem-
brane. The nanoparticle suspension was prepared in sev-
eral batches which were later combined. Each batch was
controlled by dynamic light scattering to ensure a similar
size distribution of the AgNPs in each batch. An average
nominal silver concentration of 450 μg/ml was estimated
after production of the AgNPs and was based on mea-
surements by inductively coupled plasma optical emis-
sion spectrometry.
Characterization of the nanoparticle suspension
The silver concentration of the AgNP suspensions was
determined by using a quadrupole-based inductively
coupled plasma mass spectrometer (ICP-MS 7500ce, Agi-
lent Technologies, Japan). Before measurement, the sus-
pensions were digested in 1 ml concentrated nitric acid
(PlasmaPure, SCP Science, Quebec, Canada) in a micro-
wave oven (Multiwave, Anton Paar, Graz, Austria) at ele-
vated temperature and pressure (~ 250°C, ~ 70 bar). From
three different bottles, five to six subsamples of 40 μl were
transferred to high pressure quartz vessels. After digestion
the samples were diluted 500-times with deionized water.
The concentration of Ag was quantified against an exter-
nal calibration curve (Ag stock solution 1,000 μg/ml
obtained from SCP Science, Quebec, Canada) with
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internal standardization (rhodium (Rh) stock solution
1000 μg/ml, SCP Science, Quebec, Canada). Prior to ana-
lysis the samples were further diluted (dilution factor 25),
resulting in a nitric acid concentration of approximately
2% v/v.
The silver isotope 107Ag was chosen for the ICP-MS
measurements because a slightly lower detection limit
was obtained for this isotope. The limit of detection for
the AgNP suspensions, which was estimated at 0.7 μg
Ag/ml, was based on three times the standard deviation
from repeated measurements of blank solutions.
To determine the amount of silver in the suspensions
that was not present as nanoparticles, filtrates of three
subsamples were prepared by centrifugation through a
micro centrifuge cellulose acetate filter with a molecular
weight cut-off of 12 kDa (VectaSpin Micro Centrifuge Fil-
ter, Whatman, England). A volume of 500 μl of 10-times
diluted suspension was centrifuged at 11,000 rpm (8,117 ×
g) for 30 min in a micro centrifuge (Eppendorf MiniSpin,
Eppendorf AG, Hamburg, Germany). Because the AgNPs
and the polymer could clog the membrane before all
unbound silver had passed the filter, the residue in the fil-
ter cartridge was re-suspended twice in 500 μl of deionized
water and filtered again. In order to investigate whether
any silver gradually dissolved from the AgNPs over time,
silver concentrations were determined in the filtrates at 3
and 16 weeks before and 5 months after the animal study.
Before analysis of the silver concentration by ICP-MS
the filtrates were diluted 100-times with 2% v/v nitric
acid and Rh was added as internal standard (10 ng/ml).
The limit of detection for silver in the filtrates was
0.002 μg/ml. To assure the quality of the previous
results a Sorvall Discovery 90SE ultracentrifuge (Kendro
Laboratory Products, Asheville, NC, USA) with an AH-
629 swinging bucket rotor was used as an alternative
method for separation of the nanoparticles from the ori-
ginal AgNP suspension. A 10-times diluted suspension
was transferred to a 17 ml thin walled polyallomer tube
and centrifugated at 29,000 rpm (135,293 × g) for 19 h
at 20°C; 500 μl of supernatant were taken from the sur-
face of the liquid. According to centrifugation theory
the maximum particle diameter in the supernatant was
below 1 nm [17]. The supernatant was analyzed by ICP-
MS using dissolution in acid as before.
The particle size and shape were observed by TEM
using a Philips CM100 instrument (FEI, Eindhoven, The
Netherlands) operated at 80 kV accelerating voltage.
The prepared silver suspensions were diluted 10-times
with deionized water. A drop of the suspension was
applied to a Formvar-coated copper grid.
Dynamic light scattering (DLS) and laser Doppler velo-
cimetry for characterization of hydrodynamic size and
zeta potential of the nanoparticles in solution were per-
formed using a Zetasizer Nano-ZS instrument (Malvern
Instruments, UK). Before measurements the samples
were diluted 10-times with deionized water. For DLS
250 μl of suspension were transferred to a disposable low
volume cuvette (Malvern, UK). After equilibration to a
temperature of 25°C for 2 min, five measurements were
performed using 12 runs of 10 s each. The laser power
(attenuator index) and the measurement position within
the cuvette were determined automatically by the instru-
ment. For the calculation of the nanoparticle volume size
distribution the viscosity of water was used. The influ-
ence of PVP on the viscosity was neglected because the
PVP concentration in the 10-times diluted suspensions
was only 0.1% w/v. The optical parameters for silver,
namely index of refraction n = 0.1 and index of absorp-
tion k = 4.28 at 633 nm laser wavelength were applied
according to Johnson and Christy [18]. The stability of
the nanoparticles in suspension was monitored regularly
by measuring the size distribution within 20 weeks after
arrival of the suspensions until the beginning of as well
as during the last week of the animal study.
For determination of the zeta potential, 800 μl of sus-
pension was transferred to a clear disposable zeta cell
(Malvern, UK). After equilibration to a temperature of
25°C for 2 min, five measurements were performed
where the number of runs (10 to 100) was determined
automatically by the instrument. The Smoluchowski
approximation was used for calculation of the zeta
potential.
Animal study
Four week old female Wistar Hannover Galas rats with
specific pathogen-free health status were purchased
from M&B Taconic (Lille Skensved, Denmark). Upon
arrival the rats were allowed to acclimatize for a week
before the start of the experiment. The body weight of
the animals at the beginning of the study was 107 ± 9 g
(N = 28). The rats were housed conventionally two per
cage (Macrolon, Techniplats Gazzada S. ar. L., Buguggi-
ate, Italy) with a 12:12-h reversed light/dark cycle from
7 p.m. to 7 a.m. The room temperature was 22 ± 1°C
and the relative humidity 55% ± 5%. In their cages, the
rats were given ad libitum a standard diet (Altromin rat
No.1324, Brogården, Gentofte, Denmark) and citric acid
acidified tap water (to avoid microbiological contamina-
tion of drinking water). The animal study was per-
formed under conditions approved by Danish Agency of
Protection of Experimental Animals and the in-house
Animal Welfare Committee.
The rats were randomly divided in three groups and
received either an aqueous solution of 11.5 mg/ml PVP
(vehicle control, N = 9), AgNPs (N = 9) or AgAc (N = 7)
by oral gavage twice a day for 28 days. Additionally, one
rat was included in each of the vehicle control, the AgNP
and the AgAc groups, respectively, for tissue sampling
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for electron microscopy. The dosing volume was 10 ml/
kg b.w. The aqueous solution of PVP was chosen as a
vehicle control because the same solution was used as
stabilizer for the AgNPs. PVP was also added to the
AgAc solution (AgC2H3O2, CAS number 563-63-3,
ReagentPlus, Sigma Aldrich, Denmark) to a concentra-
tion of 11.5 mg/ml. The AgAc solution remained clear
and colorless throughout the duration of the study indi-
cating that silver did not precipitate or become reduced.
The daily dose of silver in the AgNP and AgAc group
was 9.0 mg/kg b.w.
In week three of the 28-day study the rats were indivi-
dually placed in metabolism cages for 24 h for the col-
lection of urine and feces in tubes on dry ice. During
this time the animals had free access to water but not to
feed in order to eliminate the risk of contamination of
urine and feces samples.
Sample preparation
On day 29 of the study the rats fasted overnight, were
anaesthetized by CO2/O2, and decapitated. Blood from
the neck wound was collected on heparin and plasma
was prepared by centrifugation (1000 × g at 0-4°C for 10
minutes) and necropsy was performed. The brain was
removed, weighed, transferred to ice-cold 0.32 M
sucrose and homogenized at 0-4°C. Samples from the
stomach (part of corpus ventriculi), liver (lowest part of
the left median lobe), kidney (part of the right kidney),
lungs (right median lobe), and muscle (right biceps
femoris) were taken from five to six animals per group
and frozen for later ICP-MS analysis. Furthermore, sam-
ples from the liver, ileum, and kidney were fixed in 4%
neutral buffered formalin for 24 hours and embedded in
paraffin. For all rats samples were taken from the same
parts of the organs, namely the lowest part of the left
and right lateral lobe of the liver, the part of the ileum
directly above the ileo-caecal junction and a cross sec-
tion of the right kidney at the level of the renal papilla.
Paraffin sections of 3 μm thickness were obtained by
use of a microtome, collected on Superfrost plus slides
(Menzel-Gläser, Germany), and oven dried overnight at
37°C.
Determination of silver concentrations in tissue, blood
plasma, urine, and feces by ICP-MS
Thawed subsamples of approximately 250 mg tissue
(stomach, liver, kidney, lungs, and muscle) and approxi-
mately 200 μl of brain homogenate, urine, and blood
plasma were analyzed for their silver concentration.
Additionally, formalin-fixed tissue from the small intes-
tine was analyzed. The mesenteric fat was dissected
from the small intestine (sectioned between the pylorus
and the caecum) and the was sample transversally
divided in halves, which were analyzed separately. The
whole amount of collected feces per animal was dried in
an oven for 60 h at 80°C and homogenized. A dry mat-
ter content of 40 ± 4% w/w (N = 8) was determined by
weighing the feces before and after the drying proce-
dure; 10 mg of the dried feces were analyzed in dupli-
cates. One sample was taken for analysis by scanning
electron microscopy (SEM).
For assurance of the analytical accuracy the certified
reference materials (CRM) Dogfish Liver DOLT-4
(NRC-CNRC, Canada) with a certified value for silver of
930 ± 70 ng/g was included in the analysis. The dry
matter content of the reference material was 93.4% w/w.
The average determined silver concentration was 997 ±
47 ng/g (N = 30) which did not deviate from the certi-
fied value. For feces samples the analytical accuracy was
controlled by recovery of silver standard spiked to sam-
ples because no CRM with a certified silver concentra-
tion at the 100 μg/g concentration level was available.
The recovery was 106 ± 2% (N = 3).
Deionized water and 0.32 M sucrose (for the brain
homogenates) was analyzed as blank samples to ensure
that no contamination by silver from these sources
occurred during sample preparation.
All samples were digested using 3 ml concentrated nitric
acid at elevated temperature and pressure (~ 250°C; ~ 70
bar) as described previously. Following digestion, 3 ml of
concentrated hydrochloric acid (PlasmaPure, SCP Science,
Quebec, Canada) were added. For formalin-fixed tissue,
5 ml of nitric and 5 ml hydrochloric acid (added after
digestion) were used because of the larger sample size
(around 600 mg). Preliminary studies (data not included)
showed that incomplete recoveries were obtained for silver
added to the CRM Bovine Liver 1577a (NIST, Gaithers-
burg, MD, USA) spiked at 4 μg/g if no HCl was added
after digestion. The excess chloride facilitated the forma-
tion of soluble silver chloride complexes, thus preventing
precipitation of insoluble AgCl by reaction with chloride
naturally present in the biological material.
The digests were further diluted with 2% v/v nitric
acid to a final acid concentration of 8-12% v/v. The
measurements were performed as described above. The
limit of detection was estimated at 0.7 to 2.0 ng/g in the
biological samples and for feces at 200 ng/g.
The silver contents were compared using Student’s
two sample t-test (p < 0.05) after F-test of the equality
of variances using an Excel spreadsheet (Microsoft
Corp., WA, USA).
Autometallography (AMG)
After deparaffinization of the sections with xylene and
rehydration through a series of ethanol-water washes, the
slides were placed in jars filled with AMG developer [19].
The jars were transferred to a 26°C water bath covered
with a dark hood. After 60 min the AMG development
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was stopped by replacing the developer with a 5% w/v
sodium thiosulphate solution and leaving it for 10 min.
Next, the sections were rinsed in running water for sev-
eral minutes followed by a rinse in distilled water. Finally,
the sections were counterstained with 0.1% m/v toluidine
blue solution, dehydrated in ethanol-water washes, and
after a xylene wash were embedded in mounting medium
and covered with glass cover slips. Sections of control
animals were always included.
Animals and sample preparation for transmission and
scanning electron microscopy
The rats were pre-anaesthetised with inhalation of
Halothane 3% (Halocarbon Laboratories, River Edge, NJ,
USA). Anaesthesia was induced by doses of a 9:1 mixture
of Ketamine 25 mg/ml (Pfizer, Ballerup, Denmark)
90 mg/kg b.w. and Xylazine 20 mg/ml (Rompun®Vet.
BAYER, Leverkusen, Germany) 10 mg/kg b.w. The rats
were fixed by vascular perfusion through the left ventricle
of the heart with 2% v/v glutaraldehyde in 0.05 M sodium
phosphate buffer (pH 7.2) for 5 min. After fixation the
animals were stored in the same fixative. Following isola-
tion of suitable specimen blocks, the samples were rinsed
three times in 0.15 M sodium cacodylate buffer (pH 7.2)
and subsequently postfixed in 1% w/v OsO4 in 0.12 M
sodium cacodylate buffer (pH 7.2) for 2 h. Furthermore,
samples with no osmium post-fixation were included.
The specimens were dehydrated in graded series of etha-
nol, transferred to propylene oxide and embedded in
Epon according to standard procedures [20]. Sections of
approximately 50 to 60 nm thickness were cut with a
Reichert-Jung Ultracut E microtome and collected on
copper grids with Formvar supporting membranes. Sec-
tions were left unstained or stained with uranyl acetate
and lead citrate.
An aqueous feces extract was obtained by the following
procedure: 2 ml of deionized water were added to 400 mg
of wet feces and carefully shaken until a slurry was formed.
The slurry was centrifugated for 10 min at 4,700 rpm
(4,224 × g) in a Sigma 3-18 K centrifuge (Sigma, Germany)
to remove coarse feces constituents. Subsequently 700 μl
of the supernatant were transferred to Eppendorf tubes
and further centrifugated for 10 min at 13,400 rpm
(12,100 × g) in a micro centrifuge (Eppendorf MiniSpin,
Eppendorf AG, Hamburg, Germany). For TEM analysis
200 μl of the supernatant were taken and diluted two
times with deionized water.
The samples were examined with a Philips CM 100
TEM (Philips, Eindhoven, The Netherlands) operated at
an accelerating voltage of 80 kV and equipped with a SIS
MegaView2 or an OSIS Veleta digital slow scan 2 k × 2 k
CCD camera. Digital images were recorded with the ana-
lySIS or ITEM software packages and further processed
using Adobe Photoshop software (Adobe Systems
Incorporated, San Jose, California, CA, USA) to enhance
contrast and brightness.
Analysis of the elemental composition was performed
by use of a Tecnai T20 TEM (FEI, Eindhoven, The Neth-
erlands) operated at 120 kV and equipped with an INCA
energy dispersive x-ray spectrometer (Oxford instru-
ments, Oxfordshire, UK). Analyses were performed with
a focused electron probe with an accelerating voltage of
120 kV, a 14° tilt, and a counting time of 100 s. For high
resolution imaging an accelerating voltage of 200 kV was
applied.
Dried feces was analyzed by a Philips XL 30 FEG scan-
ning electron microscope (FEI, Eindhoven, Netherlands)
operated in the backscattered-electron mode at an accel-
erating voltage of 20 kV.
Results and discussion
Characterization and stability study of the silver
nanoparticle suspension
The size distribution of the AgNPs was determined by
DLS (Figure 1a). During the time from the production of
the AgNPs until the termination of the animal study the
stability of the suspension was monitored by DLS to
assure that the NPs were well dispersed during the 28
days duration of the animal experiment (Figure 1b). The
volume distribution of the hydrodynamic size of the
nanoparticles showed two peaks. The first peak (approxi-
mately 90% of the particle volume) had its maximum at
14 ± 2 nm with a peak width of 4 ± 1 nm (Figure 1a),
whereas the second peak had its maximum at 50 ± 9 nm
with a peak width of 42 ± 3 nm (N = 5). The second peak
represents approximately 11% of the total volume of
nanoparticles, but less than 0.1% of the total particle
number.
TEM was used as a second technique to confirm the
nanoparticle sizes obtained by DLS and to obtain infor-
mation about the particle shape. The nanoparticle dia-
meters observed by TEM were in agreement with the
DLS results, but no quantitative analysis was performed
with the former technique. As seen in the transmission
electron micrograph, (Figure 1a) the nanoparticles had
an almost spherical shape and the observed larger size
fraction consisted of distinct nanoparticles, and no
aggregates of AgNPs were detected.
The zeta potential of the nanoparticles was around -2
mV at a suspension pH of 5.9. Electrostatic stabilization of
NPs would typically require a zeta potential above 30 mV
or below -30 mV [21]. Accordingly, the stability of the
AgNP suspension was solely based on steric stabilization
by the PVP polymer. In contrast to electrostatic stabiliza-
tion, steric stabilization with polymers or proteins is inde-
pendent of pH and electrolyte concentration. Accordingly,
steric stabilization is useful for prevention of agglomera-
tion of nanoparticles in physiological media [21].
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The total silver concentration in the suspensions as
determined by ICP-MS of microwave-assisted nitric acid
digested samples was 628 ± 55 μg/ml (N = 16), which
was higher than the nominal concentration of 450 μg/ml.
Rats were dosed twice a day with 10 ml/kg b.w. of the
AgNP suspension, resulting in a daily silver dose of 12.6
mg/kg b.w. Because the dose of silver acetate was calcu-
lated based on the nominal concentration of the AgNP
suspension (450 μg/ml), the dose of silver as AgAc at
9 mg/kg b.w. was less than that of the AgNPs.
Most research dealing with the toxicity of silver nano-
particles ignores the possible presence of ionic silver in
the nanoparticle suspension. However, we aimed to
quantify the proportion of silver in the AgNP suspension
not present as nanoparticles. Separation of the AgNPs
from the suspension by centrifugation through 12.5 kDa
cut-off filters showed that 70 ± 1 μg/ml (N = 3) was
present in the filtrate, corresponding to 11% of the total
silver concentration. Ultracentrifugation was used to ver-
ify the results from the ultrafiltration experiment and to
rule out the possibility that silver adhered to the ultrafil-
tration membrane. The silver concentration in the super-
natant from the centrifugation was 65 μg/ml, which
confirmed the result of the ultrafiltration experiment.
Consequently, the dose per animal of this fraction of sil-
ver was approximately 1 mg Ag/kg b.w./day, and
remained stable over a time period of at least nine
months. The observation that 11% of the total silver con-
centration was not present as nanoparticles despite puri-
fication of the AgNP suspension after synthesis was in
agreement with a former study [22]. This study showed
by use of a dialysis tube that PVP-coated silver nanoparti-
cles in 5°C water released 10% of the silver in ionic form
within approximately 25 days. No further dissolution was
observed during the monitored time period of approxi-
mately 60 days. In the present study the first filtration
experiments were performed one month after synthesis.
The suspensions were stored at 4°C throughout the dura-
tion of the study. Therefore, the detected silver after fil-
tration and ultracentrifugation could be ionic silver
which was released after the synthesis of the AgNPs.
The results demonstrated that a well-characterized
nanoparticle suspension was available and dosed to the
rats throughout the study. The finding of a fraction of
non-nanoparticulate silver in the AgNP suspension pro-
vided input to a more detailed interpretation of the find-
ings from the animal study.
Organ distribution of silver
Figure 2 presents the silver organ concentration in
AgNP and AgAc exposed rats. The silver concentration
in organs of the control animals was below the limit of
detection (2 ng/g wet tissue). In general, the organ dis-
tribution pattern of silver was similar for the two silver
dosage forms, AgNPs and AgAc. The highest silver con-
centrations, listed in decreasing order, were found in
small intestine, stomach, kidney, and liver tissues of the
exposed animals. However, despite a higher oral silver
exposure to the AgNP group the resulting silver concen-
trations in kidney, lung, muscle, brain, and plasma were
lower (p < 0.05) in comparison with the corresponding
tissues from animals exposed to AgAc. When normal-
ized to the doses of 12.6 and 9 mg Ag/kg b.w./day used
for the AgNP and the AgAc groups (see additional file
1), respectively, the silver concentrations in tissues from
animals exposed to AgNPs were approximately 40-50%
of those corresponding to administration of AgAc for
kidney, stomach, brain and plasma, and 10-20% for
muscle and lungs.
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Figure 1 Size characterization and stability study of the silver
nanoparticle suspension. a) Volume size distribution of the silver
nanoparticles determined by dynamic light scattering on day 23 of
the 28-day animal study and transmission electron micrograph of
the silver nanoparticle suspension, b) Diameter value of the major
peak (peak maximum; mean ± 1s.d., N = 5) of the size distribution
recorded before and during the animal study.
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This is the first direct comparison of the distribution
and concentration of silver in rat organs following oral
administration of AgNPs or a soluble silver salt. The dis-
tribution of silver following AgAc exposure in the present
study resembled that reported in other studies where rats
were orally exposed to silver chloride or silver nitrate.
Silver was found to be distributed to several tissues,
including liver, spleen, bone marrow, lymph nodes, skin,
kidney, thyroid, heart, pancreas, adrenal glands, and
brain [9]. Furthermore, the silver organ distribution pat-
tern and concentrations of silver following exposure to
AgNPs in the present study were comparable to the
results from a 28-day study where 30 mg/kg b.w./day
AgNPs of 60 nm in diameter and stabilized with carboxy-
methylcellulose were administered orally to rats [13]. The
fact that similar silver concentrations were found in the
same organs in both studies was surprising because the
dose in the published study [13] was twice as high as that
used in the present study. This observation could be
explained by a lower absorption rate of silver from the
five times larger carboxymethylcellulose-stabilized
AgNPs [13]. Furthermore, an influence of the different
stabilizing agents on the absorption of the nanoparticles
is possible [12].
The relatively large standard deviation for silver in
small intestine and liver tissues (Figure 2) was caused by
inter-animal variation. Such variation could indicate that
despite the same dose per kg body weight, variations in
factors such as the intestinal flora and passage time may
have an influence on how much silver is actually taken
up.
Since 11% of the total silver in the AgNP suspension
was present in another form than nanoparticles, it was
possible to consider that only this fraction was absorbed
by the intestine. The non-nanoparticulate form of silver
in the AgNP suspension correspond to a dose of 1 mg
Ag/kg b.w./day in comparison to 9 mg Ag/kg b.w./day
for AgAc. Assuming similar rates of absorption, accu-
mulation, and excretion, the expected silver concentra-
tion would in this case be nine times lower in the blood
plasma and organs in comparison to blood plasma and
organs from AgAc dosed animals. However, our findings
demonstrated that the silver concentrations in stomach,
kidney, brain, and plasma of the AgNP exposed rats
were approximately one half of that found after adminis-
tration of AgAc. Therefore, the silver concentration in
tissues cannot be ascribed only to the non-nanoparticu-
late fraction of the AgNP suspensions, but must partially
contain silver originating from the AgNPs.
Excretion of silver
Table 1 presents the absolute and relative amounts of
silver in feces and urine after 24 hours of collection in
the third week of the study. The excretion is given in
both micrograms and percent of the total daily intake.
The excretion of silver with urine was low (<0.1%)
whereas a high amount of silver was excreted in feces.
This finding was in agreement with previous reports on
excretion of silver nitrate or silver iodide after oral or
intravenous administration to rats [9,23].
The excretion of silver in feces was 63 ± 23% (N = 5)
of the daily dose for AgNPs and 49 ± 21% (N = 5) of
the daily dose for AgAc. However, given the experimen-
tal design it was not possible to provide information as
to what extent silver was absorbed from the digestive
tract because fecal silver may partially be a result of bili-
ary excretion. In studies using intravenous dosing it was
shown that biliary excretion of silver was high [23] and
against a plasma-to-bile concentration gradient where
the concentration in bile was 16 to 20 times higher than
that in plasma from rats [24]. Furthermore, binding of
silver to the intestinal surface could result in a
decreased excretion of silver within the 24-hour collec-
tion of feces.
The non-significant difference between the fecal
excretion of silver in the AgNP and AgAc groups
Figure 2 Silver concentration in rat organs. Silver concentrations
(mean ± 1s.d., N = 5-7) in rat organs after 28 days oral
administration of silver nanoparticles and silver acetate. Statistically
significant differences (p < 0.05) between the groups are marked
with asterisks (*). Silver concentrations in the control animals were
below the limit of detection.
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suggested a higher fecal excretion of silver after oral
exposure to nanoparticles. This was in accordance with
the generally lower values for silver in organs of rats
that received AgNPs (Figure 2). A possible explanation
for a decreased absorption of AgNPs would be an
enhanced binding of nanoparticles to non-digestible
food components. Furthermore, the passage of the
intestinal barrier of AgNPs could be inferior to that of
AgAc.
Preliminary investigations of the presence of AgNPs in
dried feces by SEM and of an aqueous feces extract by
TEM, however, provided no evidence for the presence
of AgNPs. Further work in a targeted study is therefore
warranted, and should include optimization of the sam-
ple preparation methodology and examination of a lar-
ger number of samples before any definite statement
about the presence or absence of intact AgNPs in the
rat feces can be made.
Localization of silver in the ileum
Autometallographic staining (AMG) was used to analyze
the in situ distribution of silver in the ileum tissue. In the
ileum AMG revealed the presence of silver in the lamina
propria mainly in the tips of the villi, whereas no silver
was detected in the epithelial cell cytoplasm (Figures 3a
and 3b). Furthermore, silver was present in cells in the
submucosa. Sections of AgAc exposed rats showed the
same distribution of silver in the ileum as observed for
AgNP exposed rats (not shown). However, it must be
kept in mind that AMG cannot distinguish between silver
in the form of nanoparticles, metallic silver, or silver sele-
nide and silver sulfide nanocrystals [19]. Tissue from the
control animals showed no staining except for a faint
non-specific background which proved that no unspecific
staining occurred.
TEM was used to further characterize the silver accu-
mulated in the intestinal tissue. In the AgNP exposed
rats, mostly spherical, but strongly aggregated electron-
dense granules were found in the lysosomes of macro-
phages within the lamina propria (Figures 4a-c) and
individual granules in the basal lamina of the epithelium
(Figures 4d-f). In the AgAc exposed rats granules of
similar size were found at the same positions within the
tissue (Figure 5a and 5b). The diameter of the granules
was approximately 12 nm or smaller, which was in the
same size range as the majority of the administered
AgNPs (14 ± 4 nm). Furthermore, single granules were
found randomly distributed in the connective tissue of
the submucosa. No granules were observed in the
microvilli or within the enterocytes, which could be due
to the fact that the last dose was administered on the
day before the rats were sacrificed. The investigation of
unstained samples also showed electron dense granules
at the different locations. Thus, artifacts caused by
Table 1 24 h excretion of silver in urine and feces
urine (μg) feces (μg) urine (% of 24 h intake) feces (% of 24 h intake)
Ag-PVP nanoparticles 0.10 ± 0.05 1190 ± 430 0.005 ± 0.003 63 ± 23
Ag acetate 0.73 ± 0.23 610 ± 250 0.057 ± 0.017 49 ± 21
Absolute and relative amount of silver (mean ± 1s.d., N = 5) excreted in urine and feces within a 24 hour time period in week 3 of the study.
SM
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V
Figure 3 Autometallographic staining of ileum from a silver nanoparticle exposed rat. Optical micrographs of ileum section cuts showing,
a) Overview and b) Detail with heavy staining in the tips of the intestinal villi (V) directly below the epithelium (E), within the lamina propria
(LP), and in the submucosal region (SM).
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Figure 4 Transmission electron micrograph of an intestinal villus (ileum) from a silver nanoparticle exposed rat. Transmission electron
micrographs of ultra-thin sections (stained with uranyl acetate and lead citrate) showing a) overview of an intestinal villus (LU = lumen)
highlighting two regions of interest (I and II) in the lamina propria (LP) as well as in a region between lamina propria and the epithelium (E),
respectively; b-c) details of region I showing granules in a lysosome (Ly) within a macrophage (M); d-f) details of region II showing granules in
close proximity to a capillary (C) within the lamina propria and in the basal lamina (BL) of the epithelium. The region of interest highlighted in d)
is presented in e), whereas f) is showing the basal lamina in more detail.
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heavy metal staining with lead citrate and uranyl acetate
could be excluded.
Energy dispersive x-ray spectroscopy (EDX) was used to
confirm that the observed granules in the lysosomes of
macrophages indeed consisted of silver (Figure 6). In addi-
tion to silver signals corresponding to selenium and sulfur
were detected. These were absent in the background spec-
trum which was recorded from tissue containing no gran-
ules. An osmium signal originated from the tissue fixation
procedure in which osmium tetroxide was used as a post-
fixative. There was no qualitative difference between the
elemental composition of the granules found in the AgNP
and AgAc exposed rats.
The observation of sulfur or selenium containing silver
granules in the tissue after dosage of AgAc was in agree-
ment with results from other studies. Occupational expo-
sure of humans to silver [25] or intake of silver-containing
drugs [26,27] was found to lead to a slate blue-gray irre-
versible discoloration of the skin of patients termed
“argyria”. In the skin, granules of typically 20 to 100 nm in
diameter were observed which consisted of silver sulfide
and silver selenide [26]. In rat studies, 30 to 90 nm gran-
ules were observed in the basal lamina of the renal glo-
meruli after administration of 0.15% aqueous silver nitrate
solution in drinking water for 4 to 15 weeks [28,29]. The
proton induced X-ray emission microanalysis of silver
grains enhanced by autometallography and isolated from
kidney sections of silver exposed rats showed that the
granules consisted of silver and sulfur [19]. After exposing
rats to 0.01% silver lactate or silver nitrate dissolved in
drinking water for four weeks, AMG developed silver
grains were found in neurons and glia calls, both intracel-
lularly in lysosomes and extracellularly in basement mem-
branes [30]. Furthermore, it has very recently been shown
that silver ions are liberated in vivo from silver surfaces
[31]. AMG developed silver grains were detected both
extra- and intracellularly in tissues far away from the
implant including regional lymph nodes, liver, kidney, and
central nervous system [31]. However, the formation of
selenium and sulfur containing silver granules both in the
intestinal system of rats after oral exposure to AgAc or to
AgNPs has not been described so far.
The presence of sulfur in the in vivo formed silver
granules has been explained with the high affinity of sil-
ver and sulfur which could result in a combination of
silver ions with biological structures and constituents
with high sulfur content. Such examples include cystein
contained in collagen fibers or sulfur-containing polya-
nionic glycoproteins which are particularly abundant in
the basal lamina [19,26]. This would be in accordance
with the observed deposition of granules in the basal
lamina of the ileal epithelium in the present study (Fig-
ure 4f). The lysosomal accumulation of silver could be
caused either by direct uptake from the external milieu
such as protein-bound silver or by primary binding of
silver to intracellular molecules which were subse-
quently engulfed and digested [30]. The presence of
selenium in the silver granules has been explained by a
Ly
BLE
LP
a b100nm 100nm
Figure 5 Transmission electron micrograph of an intestinal villus (ileum) from a silver acetate exposed rat. Transmission electron
micrograph of unstained ultra-thin sections showing granules a) in a lysosome (Ly) within a macrophage in the lamina propria and b) in the
basal lamina (BL) of the epithelium.
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possible replacement of sulfur by selenium over time
because of the higher chemical stability and lower solu-
bility of silver selenide in comparison to silver sulfide
[26,32]. Another suggested mechanism has been the
direct interaction of silver with selenium bound to glu-
tathione peroxidase (GSH-Px) [26]. The formation of
the insoluble silver sulfide and selenide reduces the
toxic effects of silver ions by reducing their biological
availability and consequently preventing their interfer-
ence with normal enzymatic activities in tissues [26,32].
The present study showed the formation of silver
granules containing selenium and sulfur in lysosomes
following administration of AgNPs. We suggest two pos-
sible scenarios: 1) AgNPs were dissolved in the gastroin-
testinal system. The silver ions bound to proteins and
were deposited as granules in the lysosomes in a similar
way as silver acetate. 2) Intact AgNPs were absorbed,
bound to proteins and subsequently deposited in lyso-
somes. In the first scenario, it would be a coincidence
that the re-deposited silver formed granules with a simi-
lar size as the administered silver nanoparticles. In the
latter case, in would be a coincidence that the granules
deposited after administration of silver acetate had a
similar size as the deposited silver nanoparticles.
It is possible that the nanoparticles are taken up across
the intestinal barrier as particles with diameters less than
1 μm are extremely susceptible to absorption by the
intestinal system [11]. Gold nanoparticles with diameters
ranging from 5 to 58 nm were administered orally to
mice. It was shown that the gastrointestinal absorption of
the nanoparticles occurred paracellularly by persorption
through gaps created by extruding enterocytes [33].
However, the question is whether the AgNPs remain
intact in the gastrointestinal system prior to absorption.
The size distribution (Figure 1a) showed that the AgNP
suspension contained a small fraction of nanoparticles
equal to or larger than 50 nm in diameter. In contrast,
nanoparticles of this size fraction were not observed in
ileum by TEM despite the expected high degree of
absorption of nanoparticles in this size range [34]. This
suggests at least a partial dissolution of these large parti-
cles in the gastrointestinal system. Furthermore, other
studies have shown that polyvinylpyrrolidone (PVP)-
coated AgNPs reacted with hydrochloric acid (18%) to
form insoluble AgCl, which did not occur for bulk or
coarse-grained silver [35], and that AgNPs completely
dissolved in aqueous nitric acid solution at pH = 0.5 [36].
Although these experiments were not conducted under
physiological conditions, they indicate that AgNPs may
undergo chemical reactions and eventually dissolve in the
gastrointestinal system. Further dedicated studies that
focus on the stability of AgNPs in the gastrointestinal
environment are therefore warranted.
Localization of silver in the liver
Using AMG, silver could also be localized in the liver tis-
sue of the exposed rats. In the tissue from the untreated
control animals no staining, except for a faint non-speci-
fic background in some sections, was observed. The large
inter-animal differences in the silver concentration in the
liver observed by ICP-MS analysis were confirmed by the
AMG stained sections in which differences in the stain-
ing intensity of the liver sections from different animals
were observed, though similar parts of the livers were
investigated. The distribution pattern of silver was again
similar for AgNP and AgAc exposed animals. In general
an intense staining was observed around the central veins
and the portal tracts (see additional file 2a). In these
regions several Kupffer cells were intensely stained.
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Figure 6 Energy dispersive x-ray emission spectra of granules
in the ileum. Energy dispersive x-ray emission spectra of granules
in lysosomes of silver nanoparticle and silver acetate exposed rats
(red line) and corresponding background spectra (black line), i.e.
spectra of surrounding tissue containing no visible granules
(unstained sections). The transmission electron micrographs show
the analyzed granule containing area.
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However, there was no preferred staining of Kupffer cells
in the remaining tissue. Small AMG grains were mainly
observed in or around hepatocytes (see additional file
2b). Whether these AMG grains were present within the
hepatocytes or in the bile canaliculi could not be deter-
mined. The observations were in contrast to findings for
intravenously and intraperitoneally injected gold nano-
particles which, independent of their size, were taken up
primarily by the Kupffer cells in the liver [37] and could
indicate that no intact silver nanoparticles were deposited
in the liver. No silver granules could be detected by TEM,
which could either be related to a very small size or a low
number of the granules in the tissue. A few silver atoms
are sufficient to be visible as AMG grains after staining
[19], which might not be detectable by TEM.
Localization of silver in the kidneys
In kidney tissue silver AMG staining revealed the pre-
sence of silver in the glomeruli and proximal tubules
(see additional file 3a). In the proximal tubules single
large AMG grains were localized along the luminal
brush border of the epithelium (see additional file 3b),
whereas the staining was more homogenous in the glo-
meruli. Furthermore, heavy staining was observed in the
renal papilla and seemed to be restricted to the intersti-
tial tissue (images not presented). Again, no difference
in the silver distribution after AMG staining was
observed between AgNP and AgAc exposed animals.
However, on the basis of AMG staining no statement
about the chemical form of the deposited silver can be
made.
First investigations of an AgNP exposed rat by TEM
revealed the presence of granules in the microvilli of the
epithelial cells of a proximale tubule (see additional file
4), which was in agreement with the large AMG grains
observed by light microscopy. The granules had an irre-
gular shape and a relatively broad size distribution,
which did not coincide with that of the administered
AgNPs and could be agglomerates of the nanoparticles.
Future investigations will focus on the chemical compo-
sition of these granules.
No granules were found in the basal lamina of the
renal glomeruli by TEM. In studies which described the
deposition of silver in the basal lamina of the renal glo-
meruli, animals were exposed for several weeks by add-
ing silver to the drinking water with concentrations
around 2.5 mg/ml [38]. It was found that in immature
rats the deposition of silver took place much more gra-
dually and that the granules were smaller and more
sparsely distributed in comparison to adult rats [30].
This could explain the absence of granules visible by
TEM in the glomerular membrane in the present study.
Lung, muscle, and brain tissue were not analyzed by
microscopy because of the relatively low silver concen-
trations in those tissues.
Conclusions
In the present study, the comparison of silver acetate
and silver nanoparticles did not reveal differences with
respect to the distribution pattern of silver in organs
and tissues. The absolute silver concentrations in the
organs were generally lower after administration of
AgNPs than after administration of AgAc. This was in
agreement with an indication of a higher fecal excretion
of silver after administration of AgNPs, and further stu-
dies are warranted.
In the ileum of rats exposed to either AgNPs or AgAc,
sulfur and selenium containing silver granules of similar
size and shape were found in lysosomes of macrophages.
The deposited granules resulting from both tested forms
of silver were in the same size range as the administered
silver nanoparticles. The coinciding size ranges however,
hampered the identification of the absorption mechan-
ism of the nanoparticles. Further studies will be neces-
sary to investigate whether silver nanoparticles are
absorbed as an entity or whether they dissolve in the
gastrointestinal system followed by re-deposition in the
tissues. The accumulation of silver from AgAc and from
AgNPs points to lysosomes as a likely target for adverse
effects.
In the design of future nanotoxicity studies using oral
administration of nanomaterials to laboratory animals,
the possible dissolution of the nanoparticulate test mate-
rial in the gastrointestinal system should be taken into
account. Furthermore, inclusion of a non-nanoparticu-
late counterpart to the tested nanomaterial for compari-
son of toxicity is advisable.
Additional material
Additional file 1: Normalized silver concentrations in rat organs.
Silver concentrations (N = 5-6) in the rat organs after normalization to
the doses of 12.6 and 9 mg Ag/kg b.w./day administered to the AgNP
and the AgAc group, respectively, as well as the ratio between mean
silver organ concentrations in the AgNP and AgAc groups (marked as
dots). Statistically significant difference (p < 0.05) between the groups is
marked with asterisks (*).
Additional file 2: Autometallographic (AMG) staining of liver from
an AgNP exposed rat. a) Portal triad with heavy staining in Kupffer cells
and around the blood vessels b) AMG grains scattered around
hepatocytes
Additional file 3: Autometallographic (AMG) staining of kidney from
an AgNP exposed rat. a) Heavy staining of the glomeruli b) AMG grains
in a proximal tubule
Additional file 4: Transmission electron micrograph of a renal
proximal tubule from an AgNP exposed rat. TEM images of ultra-thin
sections (stained with uranyl acetate and lead citrate) of kidney a)
Overview of a proximal tubule with the region of interest shown in b); b)
ensemble of granules in the microvilli of the epithelia cells; c-d) higher
magnification of the granules.
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